QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 291 filers reported holding QIAGEN NV in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,042,508 | +0.1% | 99,815 | +11.3% | 0.04% | -14.6% |
Q2 2023 | $4,038,966 | +54121.6% | 89,695 | -40.0% | 0.05% | -67.3% |
Q4 2022 | $7,449 | -99.7% | 149,373 | +152.2% | 0.15% | +177.4% |
Q3 2022 | $2,445,000 | +668.9% | 59,236 | +779.5% | 0.05% | +562.5% |
Q2 2022 | $318,000 | -85.1% | 6,735 | -84.5% | 0.01% | -84.0% |
Q1 2022 | $2,135,000 | +126.4% | 43,566 | +156.8% | 0.05% | +212.5% |
Q4 2021 | $943,000 | +239.2% | 16,964 | +215.7% | 0.02% | +220.0% |
Q3 2021 | $278,000 | -66.4% | 5,374 | -68.6% | 0.01% | -68.8% |
Q2 2021 | $828,000 | -11.3% | 17,112 | -10.8% | 0.02% | -15.8% |
Q1 2021 | $934,000 | -55.9% | 19,180 | -69.4% | 0.02% | -80.0% |
Q4 2019 | $2,117,000 | +193.6% | 62,633 | +186.6% | 0.10% | +280.0% |
Q3 2019 | $721,000 | +145.2% | 21,856 | +181.5% | 0.02% | +257.1% |
Q3 2018 | $294,000 | -8.4% | 7,764 | -23.8% | 0.01% | -12.5% |
Q3 2017 | $321,000 | +18.5% | 10,188 | +8.9% | 0.01% | 0.0% |
Q1 2017 | $271,000 | -41.0% | 9,358 | -42.8% | 0.01% | -33.3% |
Q4 2016 | $459,000 | – | 16,373 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |